Skip to content
OpenCapital
Get started

Jazz Pharmaceuticals JAZZ Federal taxes

Federal taxes at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$9.25K—

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxPaidFederalAfterRefundReceived.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's federal taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's federal taxes?
Jazz Pharmaceuticals (JAZZ) reported federal taxes of $20.59M in Q4 2025.
What does federal taxes mean?
The net amount of federal income tax paid in cash.
How do you interpret federal taxes?
Provides insight into the company's actual cash tax burden versus the tax expense reported on the income statement.
How does federal taxes compare across companies?
Standard cash flow disclosure for all corporate entities.